Announcements Trials
Browse Landscape

Phase

Phase 3 15Phase NA 12Phase 4 11Phase 2 11Phase 2/3 7Phase EARLY_PHASE1 6Phase 1/2 4Phase 1 2

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 1

Conditions

Pain 1Neoplasms 1Head and Neck Neoplasms 1Depressive Disorder, Major 1Chronic Pain 1Cancer Pain 1Acute Pain 1

Interventions

pembrolizumab 410Cyclophosphamide 394Carboplatin 306Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 210Bevacizumab 209fludarabine 192Docetaxel 187Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 120Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Ketamine × Clear all
NCT05156060 2024-10-21

Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer

Vanderbilt-Ingram Cancer Center

Phase 1/2 Recruiting
64 enrolled
Head & Neck

Head and Neck Neoplasms

NCT04471818 2023-09-28

KODIAC

Instituto Nacional de Cancerologia de Mexico

Phase 1/2 Completed
19 enrolled

Depressive Disorder, Major

NCT03146806 2021-09-09

Intranasal (NAS) Ketamine for Cancer Pain

Emory University

Phase 1/2 Completed
10 enrolled 26 charts

Cancer Pain, Neoplasms, Pain

NCT02462681 2017-07-02

Ketamine as Adjunctive Analgesic With Bupivacaine in Paravertebral Analgesia for Breast Cancer Surgery

Assiut University

Phase 1/2 Completed
90 enrolled

Chronic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡